Rheumatic Disease Clinics of North America

Article	Citations
Copyright	115
Contents	67
Lessons from Cardiac and Vascular Biopsies from Patients with and without Inflammatory Rheumatic Diseases	51
Advancing Gastrointestinal Microbiota Research in Systemic Sclerosis	41
The Current Status of Exercise Applications as Medicine in Myositis Diseases on Behalf of MIHRA ICERS and MIHRA Clinical Trial Sites Network	34
Immune Checkpoint Inhibitor-induced Inflammatory Arthritis	33
Molecular Pathways in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis	24
Osteoarthritis Treatment Guidelines from Six Professional Societies	21
Kawasaki Disease and Multisystem Inflammatory Syndrome in Children	19
Machine Learning-Enhanced Autoantibody Discovery and Diagnostics in Systemic Autoimmune Rheumatic Diseases	18
Immune Checkpoint Inhibitor-induced Polymyalgia Rheumatica	17
Impact of Non-steroidal Anti-inflammatory Drugs, Glucocorticoids, and Disease-Modifying Anti-Rheumatic Drugs on Cancer Response to Immune Checkpoint Inhibitor Therapy	17
Copyright	17
Exploring the Mucosal Immune Response in Axial Spondyloarthritis Through Immunoglobulin A-Coated Microbiota	15
Forthcoming Issues	15
COPA Syndrome from Diagnosis to Treatment	14
The Short and Long of COVID-19	13
Lessons Learned from the COVID-19 Pandemic in Rheumatology	13
Artificial Intelligence in Musculoskeletal Imaging	13
Taxonomy of Quality of Care Indicators	12
Copyright	11
Contributors	11
Imaging Challenges and Developments in Large-vessel Vasculitis	11
Venous Thromboembolism in the Inflammatory Rheumatic Diseases	11
Contents	10

Pulmonary Hypertension Associated with Connective Tissue Disease	10
Contributors	10
De novo Connective Tissue Disorders as Immune-related Adverse Events	9
Expanding the Treatment Team	9
Primary Cardiac Involvement in Systemic Sclerosis	9
Copyright	9
Daniel J McCarty, MD: A Giant of Rheumatology	8
COVID-19 and Rheumatology	8
Multisystem Inflammatory Syndrome in Children and Kawasaki Disease	8
The Utility of Laboratory Investigations for the Assessment and Management of Rheumatic Immune Related Adverse Events	8
Clinically Relevant Biomarkers in Connective Tissue Disease-Associated Interstitial Lung Disease	8
Newer Immunosuppressants for Rheumatologic Disease	8
Charles L Christian	8
Mimickers of Immune Checkpoint Inhibitor-induced Inflammatory Arthritis	7
Scleroderma: Best Approaches to Patient Care	7
Cardiac MRI in Rheumatic Disease	7
Preventative Care in Scleroderma	7
Transforming Rheumatology Practice	7
Managing Immunosuppression in Vasculitis Patients in Times of Coronavirus Disease 2019	7
The Giants of Rheumatology at Johns Hopkins: Lawrence E Shulman, MD, PhD and Mary Betty Stevens, MD	6
Copyright	6
Contents	6
Sustainable Health Care and Advocacy for Rheumatologists	6
Contributors	6
E Carwile LeRoy, MD	6
Heart Failure in Rheumatic Disease	6
Global Rheumatology	5
The Spectrum of Myocardial Disease in Idiopathic Inflammatory Myopathies	5
Contributors	5
A Guide to Contemporary Clinical Practice Guidelines	5
The Challenges of New Biologic Therapies in Pediatrics	5
Imaging of Pulmonary Manifestations of Connective Tissue Disease	5
Copyright	5
Guideline Development and Implementation in Rheumatic Disease	5
Imaging of the Major Salivary Glands in Rheumatic Disease	5
Forthcoming Issues	5
Contents	4
Treatment Guidelines in Pediatric Rheumatic Diseases	4
Cardiovascular Comorbidities in Inflammatory Rheumatic Diseases	4
Therapeutic Advances in Eosinophilic Granulomatosis with Polyangiitis	4
Impacts of Storms, Precipitation, Drought, and Water Quality on Rheumatic Diseases	4
Cardiovascular Comorbidities in Inflammatory Rheumatic Diseases	4
Beyond Coronary Artery Disease	4
Myositis	4
Copyright	4
Health Care Utilization	3
Achieving Precision Medicine in Psoriatic Arthritis	3
Molecular Biomarkers and Clinical Predictors of Psoriatic Arthritis	3
Genetic Defects in Early-Onset Inflammatory Bowel Disease	3
Emerging and Expanding Infections due to Climate Change of Concern to Rheumatologists	3

Environmental Risk Factors for Osteoarthritis: The Impact on Individuals with Knee Joint Injury	3
Ambient PM2.5 Exposure and the Incidence of Systemic Lupus Erythematosus	3
Impact of Climate Change on Rheumatology Care	3
Treatment Guidelines in Gout	3
SARS-CoV-2 Infection and COVID-19 in Children	3
Recommendations for the Use of Nonsteroidal Anti-inflammatory Drugs and Cardiovascular Disease Risk	3
Expanding IPEX: Inborn Errors of Regulatory T Cells	3
Imaging in Inflammatory Bowel Disease	3
Contents	3
Environmental Triggers for Rheumatic Disease: From “Why Did I Get This?” to “How Can We Prevent This?”	3
Dual-Energy Computed Tomography Applications in Rheumatology	3
The Role of Psychology in Pediatric Rheumatic Diseases	3
Emerging Treatment Options for Inclusion Body Myositis	2
Diagnostic Evaluation for Myositis and Their Pitfalls	2
The GRADE Method	2
Lifestyle, Hormonal, and Metabolic Environmental Risks for Rheumatoid Arthritis	2
Forthcoming Issues	2
Targeting Environmental Risks to Prevent Rheumatic Disease	2
Imaging in Juvenile Idiopathic Arthritis	2
Forthcoming Issues	2
Training the Next Generation of Rheumatologists	2
The Effects of Extreme Heat on Individuals with Rheumatic Conditions	2
Forthcoming Issues	2
Myositis in 2025: Defining Subtypes, Closing Gaps, and Shaping the Future	2
Contributors	2
Treatment Approaches to Granulomatosis with Polyangiitis and Microscopic Polyangiitis	2
Rheumatology Care in an Aging World	2
Forthcoming Issues	2
Interstitial Lung Disease	2
Forthcoming Issues	2
J. Claude Bennett, MD	2
Patient-Reported Outcomes in Myositis	2
Foreword	1
Targeted Treatment of Diseases of Immune Dysregulation	1
Cardiovascular Disease in Large Vessel Vasculitis	1
Axial Imaging in Spondyloarthritis	1
Treatment Guidelines in Vasculitis	1
Forthcoming Issues	1
The Current and Future of Biomarkers of Immune Related Adverse Events	1
The Giants Of Rheumatology	1
Preface	1
Systemic Diseases and Heart Block	1
Contributors	1
Highlights of Interdisciplinary Care in Rheumatology	1
Novel Therapeutic Targets in the Management of Psoriatic Disease	1
Classification Criteria in Idiopathic Inflammatory Myopathies: Is It Time for an Update?	1
Foreword	1
The Mythology of Polymyositis	1
Treatment of Vascular Complications in Systemic Sclerosis	1
Multi-Organ System Screening, Care, and Patient Support in Systemic Sclerosis	1
Foreword	1
Treatment of Inflammatory Arthritis in Systemic Sclerosis	1
Copyright	1
Imaging in Rheumatology	1
Gerald P Rodnan	1
Rheumatology at the Threshold of Artificial Intelligence	1
Pesticides, Rheumatic Diseases, and Emerging Environmental Threats	1
Climate Change, Pollution, and Sustainability	1
Immune Checkpoint Inhibitor-induced Myositis	1
Artificial Intelligence and Social Determinants of Health	1
The Need for Classification Criteria of Immune Checkpoint Inhibitor-induced inflammatory Arthritis	1
Evidence for Biologic Drug Modifying Anti-Rheumatoid Drugs and Association with Cardiovascular Disease Risk Mitigation in Inflammatory Arthritis	1
Impact of Stress and Eco-anxiety on Rheumatic Disease	1
Long COVID for the Rheumatologist	1
Essential Informatics Tools and Computing Infrastructure for Big Data to Advance Artificial Intelligence in Rheumatology	1
Foreword	1
Forthcoming Issues	1
Contributors	1
Nathan Zvaifler	1
Artificial Intelligence Regulation in the United States	1
Vasculitis	1
Hal Holman of Stanford	1
Copyright	1
Ear, Nose, and Throat Manifestations of Vasculitis and Other Systemic Autoimmune Diseases	0
Sources of Bias in Clinical Artificial Intelligence and Applications in Rheumatology	0
Climate Change and the Exposome in Autoimmune Rheumatic Diseases	0
Contents	0
Updates in Ultrasound in Rheumatology	0
Copyright	0
Lung Microbiome in Autoimmune-Associated Interstitial Lung Disease	0

Pulmonary Complications of Biological Therapies in Inflammatory and Autoimmune Diseases	0
Forthcoming Issues	0
Forthcoming Issues	0
Gastrointestinal Tract Considerations: Part II	0
Calcinosis in Adult and Juvenile Dermatomyositis	0
Eric Bywaters and Barbara Ansell	0
Lessons from Carl M. Pearson 1919 – 1981	0
Environmental Risks for Spondyloarthropathies	0
Coronavirus Disease-2019 in the Immunocompromised Host	0
Persistent Gaps in Global Rheumatology Care and Research	0
Imaging of Rheumatic Diseases Affecting the Lower Limb	0
Emerging Concepts in the Diagnosis and Treatment of Systemic Vasculitis	0
Contents	0
Rheumatology Care Among Indigenous Populations	0
Best Approaches to the Care of Systemic Sclerosis Patients	0
Imaging in Rheumatology	0
Demystifying Artificial Intelligence	0
Myocardial Involvement in Systemic Autoimmune Rheumatic Diseases	0
Systemic Lupus Erythematosus Risk	0
Food as Medicine for Rheumatic Diseases and Planetary Health	0
Forthcoming Issues	0
Contributors	0
Foreword	0
Contributors	0
Copyright	0
The Future of Vasculitis	0
Mental Health Considerations in Chronic Disease	0
Preventative Care in Scleroderma	0
The Impact of Coronavirus Disease 2019 on Patients Living with Rheumatic Diseases	0
Lessons on Telemedicine in Rheumatology	0
Psoriatic Arthritis Updates	0
New Developments in Imaging in Crystalline Arthritis	0
Contents	0
Understanding the Spectrum of Immune Dysregulation Manifestations in Autoimmune Lymphoproliferative Syndrome and Autoimmune Lymphoproliferative Syndrome-like Disorders	0
Forthcoming Issues	0
Rheumatic Immune-related Adverse Events	0
Copyright	0
Environmental Triggers for Rheumatic Diseases	0
John R. Ward, MD: Pioneer—Clinical Trials in Rheumatology	0
Central Nervous System Vasculitis	0
Integrative Rheumatology	0
Updates in the Management of Immune-Mediated Necrotizing Myopathy	0
Guideline Development and Implementation in Rheumatic Disease	0
Contributors	0
NF-κB and Related Autoimmune and Autoinflammatory Diseases	0
Interventions to Improve COVID-19 Vaccine Hesitancy	0
Foreword	0
Rheumatic Immune-Related Adverse Events: Current Clinical Imperatives Underpin Future Novel Insights	0
Naomi Rothfield, MD, MACR	0
The Burden of Post-Acute Sequelae of Coronavirus Disease 2019 in Individuals with Rheumatic Diseases	0
Contributors	0
Forthcoming Issues	0
Toward Bridging the Gap from Artificial Intelligence in Clinical Research to Clinical Practice in Rheumatology	0
Contents	0
Axial Psoriatic Arthritis	0
Vasculitis	0
Type I Interferonopathies	0
Giant Cell Arteritis and Polymyalgia Rheumatica	0
Challenges in Developing Treatment Guidelines in Psoriatic Arthritis	0
Autoimmune Connective Tissue Diseases: Systemic Lupus Erythematosus and Rheumatoid Arthritis	0
Physical Activity for Human and Planetary Health	0
Combined Dermatology/Rheumatology Clinics for Management of Psoriatic Disease	0
Emerging Concepts in Immune Dysregulation	0
New and Emerging Rheumatic Diseases	0
Molecular Biomarkers for Predicting Treatment Response in Psoriatic Arthritis	0
Environmental Risks for Inflammatory Myopathies	0
Scleroderma: Best Approaches to Patient Care	0
Foreword	0
Environmental Risks for Systemic Sclerosis	0
Emerging Concepts in Immune Dysregulation	0
The Future of Rheumatology Leadership in Africa	0
Contributors	0
Scleroderma Skin	0
Management of Lung Manifestations in Idiopathic Inflammatory Myopathies	0
How the American College of Rheumatology Develops Guidelines	0
Cardiovascular Complications of Chronic Rheumatic Diseases	0
Isolated Aortitis	0
Vasculitis Mimics and Other Related Conditions	0
Epidemiologic Opportunities and Challenges in Studying Environmental Risk Factors for Rheumatic Diseases	0
Contributors	0
Environmental Triggers for Rheumatic Diseases	0
Contributors	0
Atherosclerotic Cardiovascular Risk Stratification in the Rheumatic Diseases:	0
Immunotherapy Toxicity Management in Clinical Practice	0
Suppressor of Cytokine Signaling 1 Haploinsufficiency	0
Vasculitis and Pregnancy	0
Vascular, Soft Tissue, and Musculoskeletal Imaging in Systemic Sclerosis	0
Copyright	0
The Role of Imaging in Diagnosis and Monitoring of Large Vessel Vasculitis	0
Newer Immunosuppressants for Rheumatologic Disease	0
Considerations for Coronavirus Disease 2019 Vaccination Among B-Cell-Depleted Patients	0
Flares of Systemic Autoimmune Rheumatic Disease Following Coronavirus Disease 2019 Vaccination	0
Review of Immunologic Manifestations of COVID-19 Infection and Vaccination	0
Patient Experience of Systemic Sclerosis–Related Calcinosis	0
Contents	0